Abnormal hormonal control of gut hydrolytic enzymes causes autoimmune attack on the CNS by production of immune-mimic and adjuvant molecules: A comprehensive explanation for the induction of multiple sclerosis

Medical Hypotheses

Volumn 68, Issue 2, 2007, Pages 364-369

  Westall, Fred C ^a  

^a Institute for Disease Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROLASE;

ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; ENZYMATIC DEGRADATION; HORMONAL REGULATION; HUMAN; INTESTINE; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL;

AUTOIMMUNE DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; DIGESTIVE SYSTEM; HORMONES; HUMANS; HYDROLASES; INCIDENCE; MODELS, IMMUNOLOGICAL; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS;

EID: 33845315500     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.06.051     Document Type: Article

References (55)

1. McAlpine D., Lumsden C.E., and Acheson E.D. Multiple sclerosis, a reappraisal (1972), Churchill Livingstone, Edinburgh 3-80
2. Westall F.C. Histo-clinical variation in multiple sclerosis: heterogeneous proteolytic immunogenic processing. Med Hypothesis 66 (2006) 566-569
3. Alvord E.C., Shaw C.M., Hruby S., and Kies M.W. Encephalitogen-induced inhibition of EAE: prevention, suppression and therapy. Ann NY Acad Sci 122 (1965) 333-345
4. Tuohy V.K., Sobel R.A., and Lees M.B. Myelin proteolipid protein induced EAE. Variation of disease expression in different strains of mice. J Immunol 140 (1988) 1868-1873
5. Amor S., Groome N., Linington C., et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of EAE in SJL and Biozzi AB/H mice. J Immunol 153 (1994) 4339-4356
6. Kaye J.F., Kerlelro de Rosbo N., Mendel I., et al. The CNS-specific myelin oligodendrocyte basic protein is encephalitogenic and a potential target antigen for MS. J Neuroimmunol 102 (2000) 189-198
7. Westall F.C., Robinson A.B., Caccam J., Jackson J.J., and Eylar E.H. Essential chemical requirements for induction of allergic encephalomyelitis. Nature 229 (1971) 22-24
8. Westall F.C., Thompson M., and Lennon V.A. Hyperacute autoimmune encephalomyelitis-unique determinant conferred by serine in a synthetic autoantigen. Nature 269 (1977) 425-427
9. Westall F.C., and Thompson M. An encephalitogenic region for rabbits. Immunochemistry 15 (1978) 189-191
10. Morris-Downes M.M., McCormack K., Baker D., Sivaprasad D., Natkunarajah J., and Amor S. Encephalitogenic and immunogenic potential of myelin-associated glycoprotein, oligo-dendrocyte-specific glycoprotein and 2,3 cyclic nucleotide 3'-phosphodiesterase in ABH and SJL mice. J Neuroimmunol 122 (2002) 20-33
11. Tuohy V.K., Lu Z., Sobel R.A., Laursen R.A., and Lees M.B. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 142 (1989) 1523-1527
12. Albouz-Abo S., Wilson J.C., Bernard C.C., and Von Itzstein M. A conformational study of the human and rat encephalitogenic myelin oligodendrocyte glycoprotein. Eur J Biochem 246 (1997) 59-70
13. Fujinami R.S., and Oldstone M.B. Amino acid homology between the encephalitogenic site of MBP and virus: mechanism for autoimmunity. Science 230 (1985) 1043-1045
14. Jahnke U., Fisher E.D., and Alvord Jr. E.C. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science 229 (1985) 282-284
15. Carnegie P.R., and Weise R. Visna and MBP. Nature 329 (1987) 294-295
16. Weise M.J., and Carnegie P.R. An approach to searching protein sequences for superfamily relationships or chronic similarities relevant to the molecular mimicry hypothesis: applications to the basic protein of myelin. J Neurochem 51 (1988) 1267-1272
17. Zhao Z.-S., Granucci F., Yeh L., Schaffer P., and Cantor H. Molecular mimicry by herpes simplex virus-type I: autoimmune disease after viral infection. Science 230 (1998) 1043-1051
18. Bachmaier K., Neu N., de la Maza L.M., Pal S., Hessel A., and Penninger J.M. Chlamydia infection and heart disease linked through antigenic mimicry. Science 283 (1999) 1335-1343
19. Benoist C., and Nathis D. Autoimmunity provoked by infection: how good is the case for molecular mimicry?. Nat Immunol 2 (2001) 797-801
20. Lang H.L.E., Jacobson H., Ikemizo S., Andersson C., Harla K., Madsen L., et al. A functional and structural basis for the cross-reactivity in multiple sclerosis. Nat Immunol 3 (2002) 940-943
21. Westall F.C. Molecular mimicry revisited: Gut bacteria and multiple sclerosis. J Clin Microbiol 44 (2006) 2099-2104
22. Westall FC. Applications of solid phase peptide synthesis. PhD. thesis. University of California, San Diego; 1970.
23. Eylar E.H., Caccam J., Jackson J.J., Westall F.C., and Robinson A.B. EAE: synthesis of disease-inducing site of basic protein. Science 168 (1970) 1220-1223
24. Westall F.C., Robinson A.B., Caccam J., Jackson J.J., and Eylar E.H. Essential chemical requirement for induction of allergic encephalomyelitis. Nature 229 (1971) 22-24
25. Westall FC. Solid phase peptide synthesis as applied to EAE. In: Field EJ, Bell TM, Carnegie PR, editors. Multiple sclerosis: progress in research. 1972; p. 72-7.
26. Westall F.C., and Thompson M. Further definition of the encephalitogenic region in guinea pigs. Immunol Commun 6 (1977) 23-31
27. Sasaki Y. Studies on encephalitogenic fragments of myelin basic protein. III. Synthesis of H-Arg-Phe-Trp-Gly-Ala-Glu-Gly-Asn-Arg-OH as an analog of encephalitogenic decapeptide. Chem Pharm Bull 22 (1974) 2188-2191
28. Suzuki K., and Sasaki Y. Studies on encephalitogen fragments of myelin basic protein. IV. Synthesis of glycine analogs of tryptophan containing fragment. Chem Pharm Bull 22 (1974) 2181-2187
29. Smeltz R.B., Wolf N.A., and Swanborg R.H. Delineation of two encephalitogenic myelin basic protein epitopes for DA rats. J Neuroimmunol 87 (1998) 43-48
30. Shapira R., Chou F.C.H., Mc Kneally S., Urban E., and Kibler R.F. Biological activity and synthesis of an encephalitogenic determinant. Science 172 (1971) 736-738
31. Lennon V.A., Westall F.C., Thompson M., and Ward E. Antigen, host and adjuvant requirements for induction of hyperacute EAE. Eur J Immunol 6 (1976) 805-810
32. Westall F.C. Hyperacute allergic encephalomyelitis. A single determinant. Immunol Commun 6 (1977) 227-237
33. Mannie M.D., Paterson P.Y., U'Prichard D.C., and Flouret G. Encephalitogenic and proliferative responses of Lewis rat lymphocytes distinguished by position 75 and 80 substituted peptides of myelin basic protein. J Immunol 142 (1989) 2608-2916
34. Mannie M.D., Paterson P.Y., U'Pritchard D.C., and Flouret G. Induction of EAE in Lewis rats. Proc Natl Acad Sci USA 82 (1985) 5515-5519
35. Westall F.C. Molecular mimicry or structural mimicry?. Mol Immunol 43 (2006) 1062-1064
36. Stevens C.E., and Hume I.D. Comparative physiology of the vertebrate digestive system. 2nd ed. (1995), Cambridge University Press, Cambridge pp. 268-286
37. Romine J., Salk J., Wiederholt W.C., Westall F.C., and Jablecki C.K. Studies on myelin basic protein administration in MS patients. 2. Preliminary report of clinical observations. In: Bauer H.J., Poser S., and Ritter G. (Eds). Progress in MS research (1980), Springer-Verlag, Heidelberg 428-433
38. Root-Bernstein R.S., and Westall F.C. Serotonin binding sites. II. Brain Res Bull 25 (1990) 826-841
39. Westall F.C., and Root-Bernstein R.S. Cause and prevention of post-infectious and post-vaccinal neuropathies in light of a new theory of autoimmunity. Lancet II (1986) 251-252
40. Chedid L., Audibert F., Lefrancier P., Choay J., and Lederer E. Modulation of the immune response by a synthetic adjuvant and analogs. Proc Nat Acad Sci USA 73 (1976) 2472-2475
41. Fox A., and Fox K. Rapid elimination of a synthetic adjuvant peptide from the circulation after systemic administration and absence of detection of natural muramyl peptides in normal serum at current analytical limits. Infect Immun 59 (1991) 1202-1205
42. Fox A., Fox K., Christensson B., Harrelson D., and Kramer K. Absolute identification of muramic acid, at trace levels, in human septic synovial fluids in vivo and absence in aseptic fluids. Infect Immun 64 (1996) 3911-3915
43. Root-Bernstein R.S., and Westall F.C. Complementarity between dual antigens in the induction of EAE. J Int Ded Biol 2 (1986) 1-10
44. Nagai Y., Akiyama K., Suzuki K., Kotani S., et al. Minimum structural requirements for encephalitogen and for adjuvant in the induction of EAE. Cell Immunol 35 (1978) 158-167
45. Westall F.C., Thompson M., Migliore-Samour D., and Jolles P. Induction of EAE using hydrosoluble adjuvants and the encephalitogenic tryptophan peptide. Immunol Commun 4 (1974) 353-359
46. Mozes E., Sela M., and Taussig M.J. Tolerance to thymus-independent antigens. Immunology 27 (1974) 641-646
47. Salk J., Romine J.S., Westall F.C., and Wiederholt W.C. Myelin basic protein studies in EAE and MS. In: Davison A.N., and Cuzner M.C. (Eds). Proceedings of the liversedge MS society symposium on the suppression of MS and EAE (1980), Academic Press, London 141-153
48. Whitacre C.C., Gienapp I.E., Meyre A., Cox K.L., and Javed N. Treatment of autoimmune disease by oral tolerance to autoantigens. Clin Immunol Immunopathol 80 (1996) 531-539
49. Root-Bernstein R.S., Yurochko F., and Westall F.C. Suppression of EAE by muramyl dipeptide. Brain Res Bull 17 (1986) 473-476
50. Leclerc C., Deriaud E., Schutze M.P., and Chedid L. Prevention of low dose streptozotocin induced diabetes by muramyl dipeptide. Int. J. Immunopharmacol 10 (1988) 293-298
51. Wood J.L., and Russo A.F. Autoregulation of cell specific MAP kinase control of the tryptophan hydroxylase promoter. J Biol Chem 276 (2001) 21267-21271
52. Root-Bernstein R.S., and Westall F.C. Sleep factors: Do muramyl peptides activate serotonin binding sites?. Lancet I (1983) 653
53. Westall F.C., Ostercamp D., and Hand D. Binding properties of n-acetyl muramyl dipeptides and related compounds. Endogenous sleep factors (1990), Academic Press, The Hague 289-297
54. Macfarlane S., and Macfarlane G.T. Bacterial diversity in the human gut. Adv Appl Microbiol 54 (2004) 261-289
55. Finegold S.M., Sutter V.I., and Mathison G.E. Normal indigenous intestinal flora. In: Hentges D.J. (Ed). Human intestinal microflora in health and disease (1993), Academic Press, New York 3-31